Rapid Testing Meets Respiratory Season

• by Jessica Allerton

• October 6, 2026

Repeat surgical interventions in non-Fuchs corneal dystrophies: insights from eight decades of histopathological and clinical data

• by Othmane Touirssa, Philip Maier, Daniel Boehringer, Claudia Auw-Haedrich, Mateusz Glegola, Thomas Reinhard, Simone Nuessle

• September 22, 2026

FDA approves combo for ESR1-mutated breast cancer

In an exploratory subgroup analysis of patients with ESR1-mutated tumors, median progression-free survival was 11.1 months with the combination and 5.5 months with imlunestrant alone.

• by Kathryn Wighton

• September 21, 2026

• 2 min

ECP 2026: Epidermal Biomarker Resolves Tricky Skin Lesions

Study investigates the diagnostic utility of epidermal CD271 IHC expression in challenging melanocytic lesions

• September 18, 2026

• 3 min